Medium-Chain Triglycerides (MCTs) for the Symptomatic Treatment of Dementia-Related Diseases: A Systematic Review
Pathomechanisms of dementias involve increasing damage to neuronal energy metabolism, resulting in degeneration-related insulin resistance and glucose hypometabolism. In this case, ketone bodies can provide an alternative energy source. Supplementation with medium-chain triglycerides (MCTs), which c...
Saved in:
| Main Authors: | Nike Meer, Tobias Fischer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Journal of Nutrition and Metabolism |
| Online Access: | http://dx.doi.org/10.1155/2024/9672969 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of medium-chain triglycerides in patients with cystic fibrosis
by: V. V. Zarubina, et al.
Published: (2024-04-01) -
A basigin antibody modulates MCTs to impact tumor metabolism and immunity
by: Heng Zhang, et al.
Published: (2025-05-01) -
A Comparative Study of Pain on Injection with Propofol Long-Chain Triglycerides Versus Propofol Medium/LongChain Triglycerides with Lignocaine
by: Aadil S. Shah, et al.
Published: (2024-11-01) -
DENR-MCTS1 heterodimerization and tRNA recruitment are required for translation reinitiation.
by: Yasar Luqman Ahmed, et al.
Published: (2018-06-01) -
Effects of Dietary Medium-Chain Triglyceride Supplementation on the Serum Metabolome of Young Adult and Senior Canines
by: Yuanlong Pan, et al.
Published: (2024-12-01)